Psilocybin in alcohol use disorder with comorbid depression - Randomized double-blind controlled pilot study.

This research study is looking at a new way to help people who are struggling with both alcohol use disorder (sometimes called alcoholism) and depression. It's an early-stage study, meaning it's one of the first steps to see if a treatment could work. The treatment being studied is psilocybin, which is a substance that comes from certain types of mushrooms. Scientists want to understand if psilocybin could be helpful for these conditions.

The main aim of this study is to check how practical and easy it is for people to go through the treatment. They are particularly interested in how many participants complete the two planned psilocybin sessions. This helps the researchers understand if this type of treatment is something that can be realistically offered to patients in the future. They will also keep track of how many people join the study, how regularly they attend appointments, and whether people stay in the study until the end.

Beyond simply looking at how practical the study is, the researchers will also be gathering information on how participants' drinking habits change. They will look at things like how often people have heavy drinking days and their overall alcohol consumption. They'll also check if mood, anxiety, and general well-being improve. This information will help them decide if larger studies are needed to explore psilocybin as a potential treatment for alcohol use disorder and depression.